| microRNAs are endogenous, noncoding RNAs. Showing both tumor‐suppressive and
oncogenic characteristics, miRNAs can regulate important processes in malignancies.
This review aimed at highlighting the recent studies on the contribution of miR‐424 to
the modulation of carcinogenesis and exploring its probable clinical effectiveness in
the diagnosis and therapy of malignancies. The data were extracted from all papers
published from 2013 until 2020. Mature miR‐424 leads to the degradation of its
target transcripts or the suppression of translation via binding to the molecular targets. miR‐424 is involved in modulating p53, PI3K/Akt, Wnt, and other molecular
pathways, thereby regulating cellular growth, apoptosis, differentiation, chemoresistance, and cancer immunity. miR‐424 was introduced as a tumor‐suppressive miR in
numerous types of cancers while as an oncogene in several cancers. Regarding the
cancer dependent role of miR‐424, it may be a prognostic and diagnostic biomarker
and a potential candidate for the treatment of cancers. |